APVO
Aptevo Therapeutics Inc

11,055
Loading...
Loading...
News
all
press releases
Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High
The company said that net proceeds from the offering will be used for the continued clinical development of product candidates, as working capital, and for other general corporate purposes.
Stocktwits·5mo ago
News Placeholder
More News
News Placeholder
Aptevo Therapeutics Stock Draws Retail Attention After Leukemia Trial Data: Retail Extremely Bullish
The company announced that all patients with acute myeloid leukemia treated with its lead candidate, mipletamig, achieved remission within 30 days in a Phase 1b trial.
Stocktwits·9mo ago
News Placeholder
Why Aptevo Therapeutics Stock Is Cratering
Aptevo announced the pricing of a public offering of 3,400,000 shares of its common stock or pre-funded warrants in lieu thereof and warrants to purchase up to an aggregate of 6,800,000 shares of its...
Benzinga·1y ago
News Placeholder
Aptevo Therapeutics (NASDAQ:APVO) Earns Hold Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO - Free Report) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the...
Zolmax·1y ago
News Placeholder
Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference
SEATTLE, WA / ACCESSWIRE / March 18, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its...
Accesswire·1y ago
News Placeholder
Aptevo Therapeutics (NASDAQ:APVO) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO Free Report) in a research note released on Sunday. The firm issued a hold rating on the biotechnology...
Zolmax·1y ago
News Placeholder
Aptevo Therapeutics, Immuron, CASI Pharmaceuticals among healthcare movers
Aptevo Therapeutics, Immuron, CASI Pharmaceuticals among healthcare movers...
SeekingAlpha.com: All News·2y ago
News Placeholder
Why Is Immuno-Oncology Focused Aptevo Therapeutics Stock Trading Higher On Thursday?
Interim results from the Phase 1 trial of ALG.APV-527 by Alligator Bioscience and Aptevo Therapeutics. Positive signs of clinical activity in breast cancer patients, with well-tolerated treatment and...
Benzinga·2y ago
News Placeholder
Aptevo Therapeutics trading resumes
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Aptevo Therapeutics trading halted, volatility trading pause
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago

Latest APVO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.